BioAtla, Inc. (BCAB) Tops Q1 EPS by 13c

BioAtla, Inc. (NASDAQ: BCAB) reported Q1 EPS of ($0.26), $0.13 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• PreveCeutical closes second tranche of private placement for $245,000
• Lantern Pharma (LTRN) files for 2.24M share offering by selling stockholders